Esteve CDMO (Esteve Química)
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Esteve CDMO (Esteve Química) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Spain
Founded:2016
Employees:2,613
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval QDVXBB
FDA · #APR-AJCC9I9E · 2018-06-01
Drug Approval VKKDTA
Health Canada · #APR-LUVUX10Z · 2022-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-YGFMPNVB
Issued: 2020-05-14
Expires: 2025-04-26
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-T8FQIBYP
Issued: 2020-10-01
Expires: 2025-01-25
Loading CDMO intelligence...
Key facts about Esteve CDMO (Esteve Química)
- Esteve CDMO (Esteve Química) is headquartered in Spain.
- Esteve CDMO (Esteve Química) was founded in 2016.
- Esteve CDMO (Esteve Química) has 2,613 employees.
- Esteve CDMO (Esteve Química)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Esteve CDMO (Esteve Química)
Directory pages this company appears in, each with the full list of matching manufacturers.